Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03769779
Other study ID # 4251KM0918
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 6, 2019
Est. completion date March 30, 2020

Study information

Verified date December 2018
Source Kemin Foods LC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Therefore, the present study is designed to contribute to the body of literature by investigating the effect of 12-weeks of lutein supplementation on multiple parameters of skin health and appearance in healthy women.


Description:

This is a randomized, double-blind, placebo-controlled, parallel twelve-week study of the performance of an oral test product to evaluate the effects of twelve weeks of lutein supplementation on skin health and appearance in healthy women. A seven-day washout period will precede the evaluation period. The subjects in each cohort will use consume one softgel of their assigned test product (treatment or placebo) daily in the morning with breakfast for 12 weeks. Changes in skin condition and appearance as well as blood chemistry will be assessed using results from expert visual grading, instrumental assessments, skin and blood assays and subjective questionnaire responses. Subjects will be recruited during the winter season to account for seasonal variations of skin parameters. Evaluation points will occur pre-application (Baseline; Week 0) and after 42 and 84 days of use (D42, D84; Week 6, Week 12). Data will be collected on the following outcomes: 1. Skin Hydration 2. Skin texture/smoothness 2. Reduction of facial fine lines and wrinkles 3. Skin elasticity and firmness 4. Sagging skin, dry skin, skin tone, appearance from expert clinical grading and subjective questionnaire responses. 6. Skin hydration 7. Skin collagen 8. Skin lipid content. 9. Skin Carotenoids


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date March 30, 2020
Est. primary completion date December 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 30 Years to 65 Years
Eligibility Inclusion Criteria: 1. Females in good health, and between the ages of 30 and 65 years old 2. Fitzpatrick Skin Type I-V 3. Mild to moderate loss of skin elasticity, wrinkles (global) and rough skin texture 4. Able to read, understand and sign an informed consent form 5. Willing and able to follow all study directions, attend study visits as scheduled and willing to accept the restrictions of the study 6. Willing and able to maintain regular diet, exercise, hydration, and sleep patterns throughout the study Exclusion Criteria: 1. Participating in any other clinical study 2. Acute or chronic disease or medical condition 3. Unreliable or unlikely to be available for the duration of the study 4. Routine use of tanning bed(s) 5. History of abnormal response to sunshine 6. Current usage of medications with contraindication of enhancing sun exposure, or medications for skin conditions. 7. History of allergic reactions, skin sensitization and/or known allergies to cosmetic ingredients, toiletries, sunscreens, etc. 8. Immunocompromised subjects 9. Subject has a history of unconventional sleep patterns 10. Started Hormone Replacement Therapy within the last three months 11. Using oral contraception for less than three months 12. Known to be pregnant, lactating or planning to become pregnant within six months 13. Unable to communicate or cooperate with the Principal Investigator due to language problems, poor mental development, or impaired cerebral function

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
FloraGLO Lutein
Lutein (FloraGLO™) in safflower oil
Safflower Oil
Safflower Oil

Locations

Country Name City State
United States International Research Services, Inc. Port Chester New York

Sponsors (1)

Lead Sponsor Collaborator
Kemin Foods LC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Objective Skin Hydration Corneometer Value ANOVA including weeks 6 and 12
Primary Subjective Skin Hydration Subjective Questionnaire Visual Analog Scale ANOVA including weeks 6 and 12
Secondary Objective Skin Texture Expert clinical grading ANOVA including weeks 6 and 12
Secondary Subjective Skin Texture Subjective Questionnaire Visual Analog Scale ANOVA including weeks 6 and 12
Secondary Objective Facial Lines and Wrinkles Expert clinical grading ANOVA including weeks 6 and 12
Secondary Subjective Facial Lines and Wrinkles Subjective Questionnaire Visual Analog Scale ANOVA including weeks 6 and 12
Secondary Objective Sagging skin, dry skin, skin tone, and overall appearance Expert clinical grading ANOVA including weeks 6 and 12
Secondary Subjective Sagging skin, dry skin, skin tone, and overall appearance Subjective Questionnaire Visual Analog Scale ANOVA including weeks 6 and 12
Secondary Objective Skin elasticity Expert clinical grading ANOVA including weeks 6 and 12
Secondary Subjective Skin elasticity Subjective Questionnaire Visual Analog Scale ANOVA including weeks 6 and 12
Secondary Skin Collagen Ultrasound Ultrasound ANOVA including weeks 6 and 12
Secondary Skin Collagen SIAsScope SIAsScope assessments ANOVA including weeks 6 and 12
Secondary Skin Lipids HPLC of tape strips ANOVA including weeks 6 and 12
Secondary Skin Carotenoids Total carotenoid concentration ANOVA including weeks 6 and 12
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1